Coco M Fuhri Snethlage
Overview
Explore the profile of Coco M Fuhri Snethlage including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
21
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de Wit D, Fuhri Snethlage C, Rampanelli E, Maasen K, Walpot N, van Raalte D, et al.
Diabetologia
. 2024 Jul;
67(10):2199-2209.
PMID: 38967668
Aims/hypothesis: The aim of this work was to investigate the association between macronutrient intakes and continuous glucose monitoring (CGM) metrics in individuals with type 1 diabetes. Methods: In 470 individuals...
2.
Fuhri Snethlage C, Balvers M, Ferwerda B, Rampanelli E, de Groen P, Roep B, et al.
Diabetologia
. 2024 Jun;
67(9):1865-1876.
PMID: 38922416
Aims/hypothesis: Use of genetic risk scores (GRS) may help to distinguish between type 1 diabetes and type 2 diabetes, but less is known about whether GRS are associated with disease...
3.
Fuhri Snethlage C, de Wit D, Wortelboer K, Rampanelli E, Hanssen N, Nieuwdorp M
Immunol Rev
. 2024 May;
325(1):46-63.
PMID: 38752578
Type 1 diabetes (T1D) is a chronic autoimmune disease targeting insulin-producing pancreatic beta cells. T1D is a multifactorial disease incorporating genetic and environmental factors. In recent years, the advances in...
4.
Fuhri Snethlage C, Meijnikman A, Mak A, Rampanelli E, Voermans B, Callender C, et al.
Eur J Endocrinol
. 2024 Apr;
190(5):391-400.
PMID: 38679966
Aims/hypothesis: The prevalence and severity of metabolic dysfunction-associated steatotic liver disease (MASLD) in type 1 diabetes remain unclear. Therefore, we investigated the prevalence and severity of MASLD in type 1...
5.
Residual β-Cell Function Is Associated With Longer Time in Range in Individuals With Type 1 Diabetes
Fuhri Snethlage C, McDonald T, Oram R, de Groen P, Rampanelli E, Schimmel A, et al.
Diabetes Care
. 2023 Aug;
47(7):1114-1121.
PMID: 37535870
Objective: Little is known about the influence of residual islet function on glycemic control in type 1 diabetes (T1D). We investigated the associations between residual β-cell function and metrics of...
6.
Fuhri Snethlage C, Nieuwdorp M, van Raalte D, Rampanelli E, Verchere B, Hanssen N
Best Pract Res Clin Endocrinol Metab
. 2021 May;
35(3):101544.
PMID: 33985913
Type 1 diabetes (T1D) is an auto-immune disease that destructs insulin-producing pancreatic beta-cells within the islets of Langerhans. The incidence of T1D has tripled over the last decades, while the...
7.
Fuhri Snethlage C, Nieuwdorp M, Hanssen N
Best Pract Res Clin Endocrinol Metab
. 2021 Jan;
35(3):101483.
PMID: 33414033
The prevalence of type 1 (T1D) and type 2 diabetes mellitus (T2D) has greatly increased worldwide over the last century. Although the exact pathophysiology of both these conditions is distinct...